Figure 2.

Indications and donor types of 146,808 HSCT by World Bank category in the years 2006–2008. The figure reflects the relative proportions of allogeneic (blue) or autologous (red) HSCT (left three columns), of allogeneic donor type [family donor (green) or unrelated donor (blue)] (central left three columns), main indications for allogeneic HSCT (central right three columns), and main indications for autologous HSCT (right three columns; for color code see figure) by low, middle of high income according to World Bank category. For definitions see the Design and Methods section. NM: non-malignant disorders; ST: solid tumors; LPD: lymphoproliferative disorders; Leuk: leukemia.